← SynDRA
NARINGIN
SynDRA canonical compound SYN0009852 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | SLCO1A2 |
|---|
| Mechanism of action | cytochrome P450 inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- cytochrome P450 inhibitor
- SLCO1A2 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CYP19A1
- ABCB1
- PTPN1
- UGT2B15
- UGT1A4
- UGT1A1
- UBE2N
- TRPA1
- TARDBP
- SLCO2B1
- SLCO1B3
- SLCO1B1
- IDH1
- CBX1
- HPSE
- HDAC6
- GSK3B
- GMNN
- FABP4
- F2
- ERG
- EHMT2
- CYCS
- USP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Naringoside
- AC1NR4U8
- 4',5,7-Trihydroxyflavanone-7-rutinoside
- 4',5,7-Trihydroxyflavanone-7-rhamnoglucoside
- aurantiin
- naringenin-7-O-neohesperidoside
- N7TD9J649B
- Naringenin-7-beta-neohesperidoside
- CHEBI:28819
- Naringenin 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside]
- Naringenin 7-O-(alpha-L-rhamnosyl-(1->2)-beta-D-glucoside)
- Citrus naringinine
- Naringenin Glycoside
- RefChem:6054
- naringenin-7-hesperidoside
- DTXCID302478
- MFCD00148888
- Naringin (Standard)
- Naringenin 7-Rhamnoglucoside
- 4'5-diOH-Flavone-7-rhgluc
- (s)-yranosyl]oxy]-
- (2S)-Naringin
- SR-01000736681
- UNII-N7TD9J649B
- Naringenine-7-rhamnosidoglucoside
- Naringin CRS
- EINECS 233-566-4
- yphenyl)chroman-4-one
- Naringin (Naringoside)
- Naringoside (Standard)
- AI3-19008
- NARINGIN [MI]
- Prestwick0_000467
- Prestwick1_000467
- Prestwick2_000467
- Prestwick3_000467
- NARINGIN [USP-RS]
Look up NARINGIN in the interactive SynDRA portal →